Characterization of the staphylococcal bacteriophage lysin CHAPK

Journal of Applied Microbiology

Volumn 111, Issue 4, 2011, Pages 1025-1035

  Fenton, M ^a   Ross, R P ^b   Mcauliffe, O ^b   O'Mahony, J ^a   Coffey, A ^a  

^a Munster Technological University   (Ireland)

^b TEAGASC FOOD RESEARCH CENTRE   (Ireland)

Author keywords

Bacteriophage; Endolysin; LysK; Lysostaphin; Peptidase

Indexed keywords

ANTIMICROBIAL AGENTS; ENZYMES; ESCHERICHIA COLI; PURIFICATION;

ANTIBACTERIALS; CATION EXCHANGE CHROMATOGRAPHY; ENDOLYSIN; ENZYMATIC PROPERTIES; LYSK; LYSOSTAPHIN; OPTIMAL REACTION CONDITION; OPTIMUM ACTIVITY; PEPTIDASE; SPECTRA'S;

BACTERIOPHAGES;

ANTIINFECTIVE AGENT; LYSINE; LYSOSTAPHIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIOPHAGE; BIOCHEMICAL COMPOSITION; CHROMATOGRAPHY; COLIFORM BACTERIUM; ENZYME ACTIVITY; HOMOGENEITY; OPTIMIZATION; PATHOGEN; PH;

ANTIBIOTIC RESISTANCE; ARTHROBACTER; ARTICLE; BACTERIOLYSIS; BACTERIUM CULTURE; BIOCHEMISTRY; CARNOBACTERIUM; CYTOLYSIS; ESCHERICHIA COLI; ION EXCHANGE CHROMATOGRAPHY; LEUCONOSTOC; MICRCOCOCCUS; NESTERENKONIA; NONHUMAN; PH; PREVALENCE; PURIFICATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PHAGE; STREPTOCOCCUS; TURBIDITY;

ARTHROBACTER; CARNOBACTERIUM; ESCHERICHIA COLI; LEUCONOSTOC; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NESTERENKONIA; STAPHYLOCOCCUS; STREPTOCOCCUS;

EID: 80052810163     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2011.05119.x     Document Type: Article

References (55)

1. Andrews, J.M. (2001) Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48(Suppl. 1), 5-16.
2. Becker, S.C., Foster-Frey, J. and Donovan, D.M. (2008) The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA. FEMS Microbiol Lett 287, 185-191.
3. Becker, S.C., Dong, S., Baker, J.R., Foster-Frey, J., Pritchard, D.G. and Donovan, D.M. (2009a) LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells. FEMS Microbiol Lett 294, 52-60.
4. Becker, S.C., Foster-Frey, J., Stodola, A.J., Anacker, D. and Donovan, D.M. (2009b) Differentially conserved staphylococcal SH3b-5 cell wall binding domains confer increased staphylolytic and streptolytic activity to a streptococcal prophage endolysin domain. Gene 443, 32-41.
5. Boyle-Vavra, S., Carey, R.B. and Daum, R.S. (2001) Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate. J Antimicrob Chemother 48, 617-625.
6. Browder, H.P., Zygmunt, W.A., Young, J.R. and Tavormina, P.A. (1965) Lysostaphin: enzymatic mode of action. Biochem Biophys Res Commun 19, 383-389.
7. Cheng, Q., Nelson, D., Zhu, S. and Fischetti, V.A. (2005) Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Antimicrob Agents Chemother 49, 111-117.
8. Climo, M.W., Patron, R.L., Goldstein, B.P. and Archer, G.L. (1998) Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis. Antimicrob Agents Chemother 42, 1355-1360.
9. Climo, M.W., Ehlert, K. and Archer, G.L. (2001) Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 45, 1431-1437.
10. Clinical and Laboratory Standards Institute (CLSI) (2009). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard-Eight Edition: Vol. 29, no. 2, M07-08. Wayne, PA: Clinical and Laboratory Standards Institute.
11. Coulon, C., Vinogradov, E., Filloux, A. and Sadovskaya, I. (2010) Chemical analysis of cellular and extracellular carbohydrates of a biofilm-forming strain Pseudomonas aeruginosa PA14. PLoS One 5, e14220.
12. Daniel, A., Euler, C., Collin, M., Chahales, P., Gorelick, K.J. and Fischetti, V.A. (2010) Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 54, 1603-1612.
13. Dinges, M.M., Orwin, P.M. and Schlievert, P.M. (2000) Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 13, 16-34.
14. Donovan, D.M., Lardeo, M. and Foster-Frey, J. (2006) Lysis of staphylococcal mastitis pathogens by bacteriophage phi11 endolysin. FEMS Microbiol Lett 265, 133-139.
15. Eady, E.A. and Cove, J.H. (2003) Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus- an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis 16, 103-124.
16. EARSS Management Team and National Representatives of EARSS (2007) European Antimicrobial Resistance Surveillance System. EARSS Annual Report 2006. pp. 1-162. Bilthoven, Netherlands: EARSS.
17. Fenton, M., Casey, P.G., Hill, C., Gahan, C.G.M., Ross, R.P., McAuliffe, O., O'Mahony, J., Maher, F. et al. (2010a) The truncated phage lysin CHAPk eliminates Staphylococcus aureus in the nares of mice. Bioeng Bugs 1, 1-4.
18. Fenton, M., Ross, P., McAuliffe, O., O'Mahony, J. and Coffey, A. (2010b) Recombinant bacteriophage lysins as antibacterials. Bioeng Bugs 1, 9-16.
19. Fischetti, V.A. (2005) Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol 13, 491-496.
20. Forsman, P., Tilsala-Timisjarvi, A. and Alatossava, T. (1997) Identification of staphylococcal and streptococcal causes of bovine mastitis using 16S-23S rRNA spacer regions. Microbiology 143(Pt 11), 3491-3500.
21. Garcia, P., Garcia, J.L., Garcia, E., Sanchez-Puelles, J.M. and Lopez, R. (1990) Modular organization of the lytic enzymes of Streptococcus pneumoniae and its bacteriophages. Gene 86, 81-88.
22. Grundling, A., Missiakas, D.M. and Schneewind, O. (2006) Staphylococcus aureus mutants with increased lysostaphin resistance. J Bacteriol 188, 6286-6297.
23. Gu, J., Xu, W., Lei, L., Huang, J., Feng, X., Sun, C., Du, C., Zuo, J. et al. (2010) A novel bacteriophage lysin, LysGH15, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection. J Clin Microbiol 49, 111-117.
24. Hamada, S. and Slade, H.D. (1980) Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol Rev 44, 331-384.
25. Hensen, S.M., Pavicic, M.J., Lohuis, J.A., De Hoog, J.A. and Poutrel, B. (2000) Location of Staphylococcus aureus within the experimentally infected bovine udder and the expression of capsular polysaccharide type 5 in situ. J Dairy Sci 83, 1966-1975.
26. Horgan, M., O'Flynn, G., Garry, J., Cooney, J., Coffey, A., Fitzgerald, G.F., Ross, R.P. and Mcauliffe, O. (2009) Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci. Appl Environ Microbiol 75, 872-874.
27. Ioannidis, O., Kakoutis, E., Katsifa, H., Rafail, S., Chatzopoulos, S., Kotronis, A. and Makrantonakis, N. (2011) Streptococcus mutans: a rare cause of retroperitoneal abscess. Adv Med Sci 56, 113-118.
28. Jado, I., Lopez, R., Garcia, E., Fenoll, A., Casal, J. and Garcia, P. (2003) Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. J Antimicrob Chemother 52, 967-973.
29. Khosla, C. and Harbury, P.B. (2001) Modular enzymes. Nature 409, 247-252.
30. Kumar, J.K. (2008) Lysostaphin: an antistaphylococcal agent. Appl Microbiol Biotechnol 80, 555-561.
31. Lee, J.H. (2003) Methicillin (Oxacillin)-resistant Staphylococcus aureus strains isolated from major food animals and their potential transmission to humans. Appl Environ Microbiol 69, 6489-6494.
32. Loeffler, J.M. and Fischetti, V.A. (2003) Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains. Antimicrob Agents Chemother 47, 375-377.
33. Loeffler, J.M., Nelson, D. and Fischetti, V.A. (2001) Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 294, 2170-2172.
34. Loeffler, J.M., Djurkovic, S. and Fischetti, V.A. (2003) Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infect Immun 71, 6199-6204.
35. Loeffler, A., Kearns, A.M., Ellington, M.J., Smith, L.J., Unt, V.E., Lindsay, J.A., Pfeiffer, D.U. and Lloyd, D.H. (2009) First isolation of MRSA ST398 from UK animals: a new challenge for infection control teams? J Hosp Infect 72, 269-271.
36. Loessner, M.J. (2005) Bacteriophage endolysins - current state of research and applications. Curr Opin Microbiol 8, 480-487.
37. Loessner, M.J., Maier, S.K., Daubek-Puza, H., Wendlinger, G. and Scherer, S. (1997) Three Bacillus cereus bacteriophage endolysins are unrelated but reveal high homology to cell wall hydrolases from different bacilli. J Bacteriol 179, 2845-2851.
38. Loessner, M.J., Kramer, K., Ebel, F. and Scherer, S. (2002) C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates. Mol Microbiol 44, 335-349.
39. Lowy, F.D. (1998) Staphylococcus aureus infections. N Engl J Med 339, 520-532.
40. McCullers, J.A., Karlstrom, A., Iverson, A.R., Loeffler, J.M. and Fischetti, V.A. (2007) Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae. PLoS Pathog 3, e28.
41. Nelson, D., Loomis, L. and Fischetti, V.A. (2001) Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad Sci USA 98, 4107-4112.
42. Nemati, M., Hermans, K., Lipinska, U., Denis, O., Deplano, A., Struelens, M., Devriese, L.A., Pasmans, F. et al. (2008) Antimicrobial resistance of old and recent Staphylococcus aureus isolates from poultry: first detection of livestock-associated methicillin-resistant strain ST398. Antimicrob Agents Chemother 52, 3817-3819.
43. O'Flaherty, S., Coffey, A., Meaney, W., Fitzgerald, G.F. and Ross, R.P. (2005) The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus. J Bacteriol 187, 7161-7164.
44. O'Mahony, R., Abbott, Y., Leonard, F.C., Markey, B.K., Quinn, P.J., Pollock, P.J., Fanning, S. and Rossney, A.S. (2005) Methicillin-resistant Staphylococcus aureus (MRSA) isolated from animals and veterinary personnel in Ireland. Vet Microbiol 109, 285-296.
45. Pastagia, M., Euler, C., Chahales, P., Fuentes-Duculan, J., Krueger, J.G. and Fischetti, V.A. (2010) A novel chimeric lysin shows superiority to mupirocin for skin decolonization of antibiotic resistant (MRSA) and sensitive (MSSA) Staphylococcus aureus. Antimicrob Agents Chemother 55, 738-744.
46. Pritchard, D.G., Dong, S., Baker, J.R. and Engler, J.A. (2004) The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30. Microbiology 150, 2079-2087.
47. Schneewind, O., Fowler, A. and Faull, K.F. (1995) Structure of the cell wall anchor of surface proteins in Staphylococcus aureus. Science 268, 103-106.
48. Schuch, R., Nelson, D. and Fischetti, V.A. (2002) A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 418, 884-889.
49. Sheehan, M.M., Garcia, J.L., Lopez, R. and Garcia, P. (1996) Analysis of the catalytic domain of the lysin of the lactococcal bacteriophage Tuc2009 by chimeric gene assembling. FEMS Microbiol Lett 140, 23-28.
50. Van Duijkeren, E., Moleman, M., Sloet Van Oldruitenborgh-Oosterbaan, M.M., Multem, J., Troelstra, A., Fluit, A.C., Van Wamel, W.J., Houwers, D.J. et al. (2009) Methicillin-resistant Staphylococcus aureus in horses and horse personnel: an investigation of several outbreaks. Vet Microbiol 141, 96-102.
51. Voss, A., Loeffen, F., Bakker, J., Klaassen, C. and Wulf, M. (2005) Methicillin-resistant Staphylococcus aureus in pig farming. Emerg Infect Dis 11, 1965-1966.
52. Yang, X.Y., Li, C.R., Lou, R.H., Wang, Y.M., Zhang, W.X., Chen, H.Z., Huang, Q.S., Han, Y.X. et al. (2007) In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from hospitals in Beijing, China. J Med Microbiol 56, 71-76.
53. Yoong, P., Schuch, R., Nelson, D. and Fischetti, V.A. (2006) PlyPH, a bacteriolytic enzyme with a broad pH range of activity and lytic action against Bacillus anthracis. J Bacteriol 188, 2711-2714.
54. Young, I., Wang, I. and Roof, W.D. (2000) Phages will out: strategies of host cell lysis. Trends Microbiol 8, 120-128.
55. Zimmer, M., Vukov, N., Scherer, S. and Loessner, M.J. (2002) The murein hydrolase of the bacteriophage phi3626 dual lysis system is active against all tested Clostridium perfringens strains. Appl Environ Microbiol 68, 5311-5317.